04/12/2016 - 12:31pm

A new report from Accenture is shedding light on a new focus on the part of pharmaceutical companies: investing in patient-centered capabilities and services.

04/11/2016 - 12:38pm

The launch makes Mylan the only manufacturer with five strengths for its generic Lopressor, a treatment for hypertension.

04/11/2016 - 12:09pm

California pharmacists are authorized to furnish oral, transdermal, vaginal and Depo injection forms of prescription birth control under a new law that took effect April 8. 

04/11/2016 - 10:54am

When implementation of Walgreens' naloxone program is complete, naloxone will be available without a prescription in more than 5,800 of Walgreens nearly 8,200 stores.

04/07/2016 - 12:16pm

So far in 2016, there have been multiple Part D plans and PBMs that have been utilizing MAC drug pricing values that are "far below what would be considered to be reasonably approaching market prices for drugs," the letter noted.

04/07/2016 - 12:06pm

The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs. 

04/07/2016 - 9:10am

 The drug is indicated to treat cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome, as well as to prevent CMV in high-risk kidney, heart, or kidney-pancreas transplant.

04/07/2016 - 8:56am

Lamivudine tablets had U.S. sales of about $27.1 million for the 12 months ended December 2015.

04/06/2016 - 11:54am

Hospira, now a Pfizer company, entered into an agreement with Celltrion and Celltrion Healthcare in 2009 for several potential biosimilar products, including the recently-approved Inflectra.